UNSPSC 85493549: Replacement of papillary muscle with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of papillary muscle with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02RD47Z

UNSPSC 85493549 Replacement of papillary muscle with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code showing little relevant recent activity in state and local procurement. The code's nominal scope—a surgical procedure for cardiac repair—does not align with the opportunities posted under this classification. Recent state and local solicitations tagged to this code procure independent medical evaluation services, occupational health surveillance, surgical benefit carve-out administration, pharmacy benefit management, temporary health professional staffing, and specialty medical services for detained youth. None of these services involve papillary muscle replacement or tissue substitution procedures. The mismatch between the code's name and the work actually being bought suggests either miscoding by the issuing bodies or use of the code as a catchall for unrelated medical services procurement.

The recent opportunities originate from diverse issuing bodies—city retirement offices (Phoenix), municipal health systems (Long Beach, Santa Clara), state transportation departments (Washington), county health authorities (Harris County, Collier County)—across multiple states including Arizona, California, Washington, and Florida. Activity spans administrative medical services, employee benefits contracting, and workforce management rather than surgical procedures or tissue-based medical devices. Without genuine alignment between the Commodity code's technical definition and the work state and local governments are actually purchasing under it, the code does not represent a meaningful procurement market segment for vendors focused on cardiac surgical innovation or tissue-substitute products.